Get Real Time Here
| Open0.280 | Close- |
| Vol / Avg.11.403K / 198.720K | Mkt Cap11.435M |
| Day Range0.280 - 0.291 | 52 Wk Range0.255 - 2.050 |
Atreca Stock (NASDAQ:BCEL), Quotes and News Summary
Atreca Stock (NASDAQ: BCEL) stock price, news, charts, stock research, profile.
| Open0.280 | Close- |
| Vol / Avg.11.403K / 198.720K | Mkt Cap11.435M |
| Day Range0.280 - 0.291 | 52 Wk Range0.255 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.570 | -0.490 | 0.0800 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Wedbush | Robert Driscoll | Downgrades | OutperformNeutral | Lowers | 4.00 | 1.00 |
| 2023-08-11 | Stifel | Stephen Willey | Downgrades | BuyHold | Lowers | 4.00 | 1.00 |
| 2023-08-11 | HC Wainwright & Co. | Joseph Pantginis | Downgrades | BuyNeutral | - | - | - |
| 2023-06-05 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCEL | Atreca | 11.92% | 11.4M |
| ERNA | Eterna Therapeutics | -1.91% | 11.1M |
| IMPL | Impel Pharmaceuticals | 2.82% | 13.2M |
| IMRN | Immuron | -1% | 11.2M |
| DOMH | Dominari Holdings | 2.13% | 12.7M |
How do I buy Atreca (BCEL) stock?
You can purchase shares of Atreca (NASDAQ: BCEL) through any online brokerage.
Who are Atreca's (BCEL) competitors?
Other companies in Atreca’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Comera Life Sciences (NASDAQ:CMRA).
What is the target price for Atreca (BCEL) stock?
The latest price target for Atreca (NASDAQ: BCEL) was reported by Wedbush on Monday, August 14, 2023. The analyst firm set a price target for 1.00 expecting BCEL to rise to within 12 months (a possible 243.64% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Atreca (BCEL)?
The stock price for Atreca (NASDAQ: BCEL) is $0.291 last updated Today at September 27, 2023 at 2:11 PM UTC.
Does Atreca (BCEL) pay a dividend?
There is no dividend information for Atreca.
When is Atreca (NASDAQ:BCEL) reporting earnings?
Atreca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Atreca (BCEL) going to split?
There is no upcoming split for Atreca.
What sector and industry does Atreca (BCEL) operate in?
Atreca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Atreca Stock (NASDAQ:BCEL), Quotes and News Summary
Atreca Stock (NASDAQ: BCEL) stock price, news, charts, stock research, profile.
| Open0.280 | Close- |
| Vol / Avg.11.403K / 198.720K | Mkt Cap11.435M |
| Day Range0.280 - 0.291 | 52 Wk Range0.255 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.570 | -0.490 | 0.0800 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Wedbush | Robert Driscoll | Downgrades | OutperformNeutral | Lowers | 4.00 | 1.00 |
| 2023-08-11 | Stifel | Stephen Willey | Downgrades | BuyHold | Lowers | 4.00 | 1.00 |
| 2023-08-11 | HC Wainwright & Co. | Joseph Pantginis | Downgrades | BuyNeutral | - | - | - |
| 2023-06-05 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCEL | Atreca | 11.92% | 11.4M |
| ERNA | Eterna Therapeutics | -1.91% | 11.1M |
| IMPL | Impel Pharmaceuticals | 2.82% | 13.2M |
| IMRN | Immuron | -1% | 11.2M |
| DOMH | Dominari Holdings | 2.13% | 12.7M |
How do I buy Atreca (BCEL) stock?
You can purchase shares of Atreca (NASDAQ: BCEL) through any online brokerage.
Who are Atreca's (BCEL) competitors?
Other companies in Atreca’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Comera Life Sciences (NASDAQ:CMRA).
What is the target price for Atreca (BCEL) stock?
The latest price target for Atreca (NASDAQ: BCEL) was reported by Wedbush on Monday, August 14, 2023. The analyst firm set a price target for 1.00 expecting BCEL to rise to within 12 months (a possible 243.64% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Atreca (BCEL)?
The stock price for Atreca (NASDAQ: BCEL) is $0.291 last updated Today at September 27, 2023 at 2:11 PM UTC.
Does Atreca (BCEL) pay a dividend?
There is no dividend information for Atreca.
When is Atreca (NASDAQ:BCEL) reporting earnings?
Atreca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Atreca (BCEL) going to split?
There is no upcoming split for Atreca.
What sector and industry does Atreca (BCEL) operate in?
Atreca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Atreca Stock (NASDAQ:BCEL), Quotes and News Summary
Atreca Stock (NASDAQ: BCEL) stock price, news, charts, stock research, profile.
| Open0.280 | Close- |
| Vol / Avg.11.403K / 198.720K | Mkt Cap11.435M |
| Day Range0.280 - 0.291 | 52 Wk Range0.255 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.570 | -0.490 | 0.0800 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Wedbush | Robert Driscoll | Downgrades | OutperformNeutral | Lowers | 4.00 | 1.00 |
| 2023-08-11 | Stifel | Stephen Willey | Downgrades | BuyHold | Lowers | 4.00 | 1.00 |
| 2023-08-11 | HC Wainwright & Co. | Joseph Pantginis | Downgrades | BuyNeutral | - | - | - |
| 2023-06-05 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCEL | Atreca | 11.92% | 11.4M |
| ERNA | Eterna Therapeutics | -1.91% | 11.1M |
| IMPL | Impel Pharmaceuticals | 2.82% | 13.2M |
| IMRN | Immuron | -1% | 11.2M |
| DOMH | Dominari Holdings | 2.13% | 12.7M |
How do I buy Atreca (BCEL) stock?
You can purchase shares of Atreca (NASDAQ: BCEL) through any online brokerage.
Who are Atreca's (BCEL) competitors?
Other companies in Atreca’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Comera Life Sciences (NASDAQ:CMRA).
What is the target price for Atreca (BCEL) stock?
The latest price target for Atreca (NASDAQ: BCEL) was reported by Wedbush on Monday, August 14, 2023. The analyst firm set a price target for 1.00 expecting BCEL to rise to within 12 months (a possible 243.64% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Atreca (BCEL)?
The stock price for Atreca (NASDAQ: BCEL) is $0.291 last updated Today at September 27, 2023 at 2:11 PM UTC.
Does Atreca (BCEL) pay a dividend?
There is no dividend information for Atreca.
When is Atreca (NASDAQ:BCEL) reporting earnings?
Atreca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Atreca (BCEL) going to split?
There is no upcoming split for Atreca.
What sector and industry does Atreca (BCEL) operate in?
Atreca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Atreca Stock (NASDAQ:BCEL), Quotes and News Summary
Atreca Stock (NASDAQ: BCEL) stock price, news, charts, stock research, profile.
| Open0.280 | Close- |
| Vol / Avg.11.403K / 198.720K | Mkt Cap11.435M |
| Day Range0.280 - 0.291 | 52 Wk Range0.255 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.570 | -0.490 | 0.0800 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Wedbush | Robert Driscoll | Downgrades | OutperformNeutral | Lowers | 4.00 | 1.00 |
| 2023-08-11 | Stifel | Stephen Willey | Downgrades | BuyHold | Lowers | 4.00 | 1.00 |
| 2023-08-11 | HC Wainwright & Co. | Joseph Pantginis | Downgrades | BuyNeutral | - | - | - |
| 2023-06-05 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCEL | Atreca | 11.92% | 11.4M |
| ERNA | Eterna Therapeutics | -1.91% | 11.1M |
| IMPL | Impel Pharmaceuticals | 2.82% | 13.2M |
| IMRN | Immuron | -1% | 11.2M |
| DOMH | Dominari Holdings | 2.13% | 12.7M |
How do I buy Atreca (BCEL) stock?
You can purchase shares of Atreca (NASDAQ: BCEL) through any online brokerage.
Who are Atreca's (BCEL) competitors?
Other companies in Atreca’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Comera Life Sciences (NASDAQ:CMRA).
What is the target price for Atreca (BCEL) stock?
The latest price target for Atreca (NASDAQ: BCEL) was reported by Wedbush on Monday, August 14, 2023. The analyst firm set a price target for 1.00 expecting BCEL to rise to within 12 months (a possible 243.64% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Atreca (BCEL)?
The stock price for Atreca (NASDAQ: BCEL) is $0.291 last updated Today at September 27, 2023 at 2:11 PM UTC.
Does Atreca (BCEL) pay a dividend?
There is no dividend information for Atreca.
When is Atreca (NASDAQ:BCEL) reporting earnings?
Atreca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Atreca (BCEL) going to split?
There is no upcoming split for Atreca.
What sector and industry does Atreca (BCEL) operate in?
Atreca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Atreca Stock (NASDAQ:BCEL), Quotes and News Summary
Atreca Stock (NASDAQ: BCEL) stock price, news, charts, stock research, profile.
| Open0.280 | Close- |
| Vol / Avg.11.403K / 198.720K | Mkt Cap11.435M |
| Day Range0.280 - 0.291 | 52 Wk Range0.255 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.570 | -0.490 | 0.0800 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Wedbush | Robert Driscoll | Downgrades | OutperformNeutral | Lowers | 4.00 | 1.00 |
| 2023-08-11 | Stifel | Stephen Willey | Downgrades | BuyHold | Lowers | 4.00 | 1.00 |
| 2023-08-11 | HC Wainwright & Co. | Joseph Pantginis | Downgrades | BuyNeutral | - | - | - |
| 2023-06-05 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCEL | Atreca | 11.92% | 11.4M |
| ERNA | Eterna Therapeutics | -1.91% | 11.1M |
| IMPL | Impel Pharmaceuticals | 2.82% | 13.2M |
| IMRN | Immuron | -1% | 11.2M |
| DOMH | Dominari Holdings | 2.13% | 12.7M |
How do I buy Atreca (BCEL) stock?
You can purchase shares of Atreca (NASDAQ: BCEL) through any online brokerage.
Who are Atreca's (BCEL) competitors?
Other companies in Atreca’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Comera Life Sciences (NASDAQ:CMRA).
What is the target price for Atreca (BCEL) stock?
The latest price target for Atreca (NASDAQ: BCEL) was reported by Wedbush on Monday, August 14, 2023. The analyst firm set a price target for 1.00 expecting BCEL to rise to within 12 months (a possible 243.64% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Atreca (BCEL)?
The stock price for Atreca (NASDAQ: BCEL) is $0.291 last updated Today at September 27, 2023 at 2:11 PM UTC.
Does Atreca (BCEL) pay a dividend?
There is no dividend information for Atreca.
When is Atreca (NASDAQ:BCEL) reporting earnings?
Atreca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Atreca (BCEL) going to split?
There is no upcoming split for Atreca.
What sector and industry does Atreca (BCEL) operate in?
Atreca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Atreca Stock (NASDAQ:BCEL), Quotes and News Summary
Atreca Stock (NASDAQ: BCEL) stock price, news, charts, stock research, profile.
| Open0.280 | Close- |
| Vol / Avg.11.403K / 198.720K | Mkt Cap11.435M |
| Day Range0.280 - 0.291 | 52 Wk Range0.255 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.570 | -0.490 | 0.0800 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Wedbush | Robert Driscoll | Downgrades | OutperformNeutral | Lowers | 4.00 | 1.00 |
| 2023-08-11 | Stifel | Stephen Willey | Downgrades | BuyHold | Lowers | 4.00 | 1.00 |
| 2023-08-11 | HC Wainwright & Co. | Joseph Pantginis | Downgrades | BuyNeutral | - | - | - |
| 2023-06-05 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCEL | Atreca | 11.92% | 11.4M |
| ERNA | Eterna Therapeutics | -1.91% | 11.1M |
| IMPL | Impel Pharmaceuticals | 2.82% | 13.2M |
| IMRN | Immuron | -1% | 11.2M |
| DOMH | Dominari Holdings | 2.13% | 12.7M |
How do I buy Atreca (BCEL) stock?
You can purchase shares of Atreca (NASDAQ: BCEL) through any online brokerage.
Who are Atreca's (BCEL) competitors?
Other companies in Atreca’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Comera Life Sciences (NASDAQ:CMRA).
What is the target price for Atreca (BCEL) stock?
The latest price target for Atreca (NASDAQ: BCEL) was reported by Wedbush on Monday, August 14, 2023. The analyst firm set a price target for 1.00 expecting BCEL to rise to within 12 months (a possible 243.64% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Atreca (BCEL)?
The stock price for Atreca (NASDAQ: BCEL) is $0.291 last updated Today at September 27, 2023 at 2:11 PM UTC.
Does Atreca (BCEL) pay a dividend?
There is no dividend information for Atreca.
When is Atreca (NASDAQ:BCEL) reporting earnings?
Atreca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Atreca (BCEL) going to split?
There is no upcoming split for Atreca.
What sector and industry does Atreca (BCEL) operate in?
Atreca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Atreca Stock (NASDAQ:BCEL), Quotes and News Summary
Atreca Stock (NASDAQ: BCEL) stock price, news, charts, stock research, profile.
| Open0.280 | Close- |
| Vol / Avg.11.403K / 198.720K | Mkt Cap11.435M |
| Day Range0.280 - 0.291 | 52 Wk Range0.255 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.570 | -0.490 | 0.0800 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Wedbush | Robert Driscoll | Downgrades | OutperformNeutral | Lowers | 4.00 | 1.00 |
| 2023-08-11 | Stifel | Stephen Willey | Downgrades | BuyHold | Lowers | 4.00 | 1.00 |
| 2023-08-11 | HC Wainwright & Co. | Joseph Pantginis | Downgrades | BuyNeutral | - | - | - |
| 2023-06-05 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCEL | Atreca | 11.92% | 11.4M |
| ERNA | Eterna Therapeutics | -1.91% | 11.1M |
| IMPL | Impel Pharmaceuticals | 2.82% | 13.2M |
| IMRN | Immuron | -1% | 11.2M |
| DOMH | Dominari Holdings | 2.13% | 12.7M |
How do I buy Atreca (BCEL) stock?
You can purchase shares of Atreca (NASDAQ: BCEL) through any online brokerage.
Who are Atreca's (BCEL) competitors?
Other companies in Atreca’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Comera Life Sciences (NASDAQ:CMRA).
What is the target price for Atreca (BCEL) stock?
The latest price target for Atreca (NASDAQ: BCEL) was reported by Wedbush on Monday, August 14, 2023. The analyst firm set a price target for 1.00 expecting BCEL to rise to within 12 months (a possible 243.64% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Atreca (BCEL)?
The stock price for Atreca (NASDAQ: BCEL) is $0.291 last updated Today at September 27, 2023 at 2:11 PM UTC.
Does Atreca (BCEL) pay a dividend?
There is no dividend information for Atreca.
When is Atreca (NASDAQ:BCEL) reporting earnings?
Atreca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Atreca (BCEL) going to split?
There is no upcoming split for Atreca.
What sector and industry does Atreca (BCEL) operate in?
Atreca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Atreca Stock (NASDAQ:BCEL), Quotes and News Summary
Atreca Stock (NASDAQ: BCEL) stock price, news, charts, stock research, profile.
| Open0.280 | Close- |
| Vol / Avg.11.403K / 198.720K | Mkt Cap11.435M |
| Day Range0.280 - 0.291 | 52 Wk Range0.255 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.570 | -0.490 | 0.0800 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Wedbush | Robert Driscoll | Downgrades | OutperformNeutral | Lowers | 4.00 | 1.00 |
| 2023-08-11 | Stifel | Stephen Willey | Downgrades | BuyHold | Lowers | 4.00 | 1.00 |
| 2023-08-11 | HC Wainwright & Co. | Joseph Pantginis | Downgrades | BuyNeutral | - | - | - |
| 2023-06-05 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCEL | Atreca | 11.92% | 11.4M |
| ERNA | Eterna Therapeutics | -1.91% | 11.1M |
| IMPL | Impel Pharmaceuticals | 2.82% | 13.2M |
| IMRN | Immuron | -1% | 11.2M |
| DOMH | Dominari Holdings | 2.13% | 12.7M |
How do I buy Atreca (BCEL) stock?
You can purchase shares of Atreca (NASDAQ: BCEL) through any online brokerage.
Who are Atreca's (BCEL) competitors?
Other companies in Atreca’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Comera Life Sciences (NASDAQ:CMRA).
What is the target price for Atreca (BCEL) stock?
The latest price target for Atreca (NASDAQ: BCEL) was reported by Wedbush on Monday, August 14, 2023. The analyst firm set a price target for 1.00 expecting BCEL to rise to within 12 months (a possible 243.64% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Atreca (BCEL)?
The stock price for Atreca (NASDAQ: BCEL) is $0.291 last updated Today at September 27, 2023 at 2:11 PM UTC.
Does Atreca (BCEL) pay a dividend?
There is no dividend information for Atreca.
When is Atreca (NASDAQ:BCEL) reporting earnings?
Atreca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Atreca (BCEL) going to split?
There is no upcoming split for Atreca.
What sector and industry does Atreca (BCEL) operate in?
Atreca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Atreca Stock (NASDAQ:BCEL), Quotes and News Summary
Atreca Stock (NASDAQ: BCEL) stock price, news, charts, stock research, profile.
| Open0.280 | Close- |
| Vol / Avg.11.403K / 198.720K | Mkt Cap11.435M |
| Day Range0.280 - 0.291 | 52 Wk Range0.255 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.570 | -0.490 | 0.0800 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Wedbush | Robert Driscoll | Downgrades | OutperformNeutral | Lowers | 4.00 | 1.00 |
| 2023-08-11 | Stifel | Stephen Willey | Downgrades | BuyHold | Lowers | 4.00 | 1.00 |
| 2023-08-11 | HC Wainwright & Co. | Joseph Pantginis | Downgrades | BuyNeutral | - | - | - |
| 2023-06-05 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCEL | Atreca | 11.92% | 11.4M |
| ERNA | Eterna Therapeutics | -1.91% | 11.1M |
| IMPL | Impel Pharmaceuticals | 2.82% | 13.2M |
| IMRN | Immuron | -1% | 11.2M |
| DOMH | Dominari Holdings | 2.13% | 12.7M |
How do I buy Atreca (BCEL) stock?
You can purchase shares of Atreca (NASDAQ: BCEL) through any online brokerage.
Who are Atreca's (BCEL) competitors?
Other companies in Atreca’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Comera Life Sciences (NASDAQ:CMRA).
What is the target price for Atreca (BCEL) stock?
The latest price target for Atreca (NASDAQ: BCEL) was reported by Wedbush on Monday, August 14, 2023. The analyst firm set a price target for 1.00 expecting BCEL to rise to within 12 months (a possible 243.64% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Atreca (BCEL)?
The stock price for Atreca (NASDAQ: BCEL) is $0.291 last updated Today at September 27, 2023 at 2:11 PM UTC.
Does Atreca (BCEL) pay a dividend?
There is no dividend information for Atreca.
When is Atreca (NASDAQ:BCEL) reporting earnings?
Atreca’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Atreca (BCEL) going to split?
There is no upcoming split for Atreca.
What sector and industry does Atreca (BCEL) operate in?
Atreca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.